| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $48.61B | +2.1% |
| Gross profit | $48.61B | — |
| Operating income | $3.95B | — |
| Net income | $2.21B | -36.9% |
| Gross margin | 100.0% | Net margin 4.5% |
| Segment | Revenue | Share |
|---|---|---|
| Reportable Segment Aggregation Before Other Operating | $62.15B | 127.9% |
| All Other Segments | $0.13B | 0.3% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | $1.07B | 2.2% |
| Tax & other | $1.74B | 3.6% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
CMG ・ CB ・ CHD ・ CIEN ・ CI ・ CINF ・ CTAS ・ CSCO ・ C ・ CFG ・ CLX ・ CME
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies